Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case‐Control Study-Reference-Cited by-同舟云学术

Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case‐Control Study

Published:2021-08-12 Issue:9 Volume:5 Page:
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Griffin Lanny V.¹,Warner Elizabeth²,Palnitkar Saroj²,Qiu Shijing²,Honasoge Mahalakshmi³,Griffin Shawna G.¹,Divine George⁴,Rao Sudhaker D.²³^ORCID

Affiliation:

1. California Polytechnic State University (Cal Poly) San Luis Obispo CA USA

2. Bone & Mineral Research Laboratory Henry Ford Health System/Wayne State University Integrative Biosciences (IBio) Research Facility Detroit MI USA

3. Division of Endocrinology, Diabetes, and Bone & Mineral Disorders Henry Ford Health System Detroit MI USA

4. Department of Public Health Sciences Henry Ford Health System Detroit MI USA

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm4.10523

Reference53 articles.

1. Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy

2. Unusual mid-shaft fractures during long-term bisphosphonate therapy

3. Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts

4. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management

5. Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of bone turnover suppression in atypical femoral fractures and osteoporotic hip fractures;Scientific Reports;2024-08-28

2. Differences in tissue-level properties as assessed by nano-scratching in patients with and without atypical femur fractures on long-term bisphosphonate therapy: a proof-of-concept pilot study;JBMR Plus;2024-07-25

3. Is there genetic susceptibility for atypical femoral fractures?;Injury;2024-02